Last reviewed · How we verify
Cyclic peptide Fertiline — Competitive Intelligence Brief
phase 3
GnRH agonist or reproductive hormone modulator
Reproductive Health / Fertility
Small molecule
Live · refreshed every 30 min
Target snapshot
Cyclic peptide Fertiline (Cyclic peptide Fertiline) — Assistance Publique - Hôpitaux de Paris. Fertiline is a cyclic peptide that modulates reproductive hormone signaling to enhance fertility.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cyclic peptide Fertiline TARGET | Cyclic peptide Fertiline | Assistance Publique - Hôpitaux de Paris | phase 3 | GnRH agonist or reproductive hormone modulator |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (GnRH agonist or reproductive hormone modulator class)
- Assistance Publique - Hôpitaux de Paris · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cyclic peptide Fertiline CI watch — RSS
- Cyclic peptide Fertiline CI watch — Atom
- Cyclic peptide Fertiline CI watch — JSON
- Cyclic peptide Fertiline alone — RSS
- Whole GnRH agonist or reproductive hormone modulator class — RSS
Cite this brief
Drug Landscape (2026). Cyclic peptide Fertiline — Competitive Intelligence Brief. https://druglandscape.com/ci/cyclic-peptide-fertiline. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab